Browse
Submit Data
Databases
API
Help

Dataset Information

21 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-Bromo-2-methyl-1-[4-(methyl-sulfan-yl)phen-yl]propan-1-one.

ABSTRACT: In the title compound, C(11)H(13)BrOS, the thio-ether unit and the phenyl ring adopt an essentially planar conformation, with a maximum deviation of 0.063?Å. In the crystal, mol-ecules are linked by C-H?O hydrogen bonds, extending in zigzag chains along the b axis. A weak intra-molecular C-H?Br hydrogen bond is also observed, which forms an S(6) ring motif.

SUBMITTER: Liu F

PROVIDER: S-EPMC3379344 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

2-Bromo-2-methyl-1-[4-(methyl-sulfan-yl)phen-yl]propan-1-one.

Liu Fei F Ren Shi-Ying SY Yang Wei-Ji WJ

Acta crystallographica. Section E, Structure reports online 20120516 Pt 6

In the title compound, C(11)H(13)BrOS, the thio-ether unit and the phenyl ring adopt an essentially planar conformation, with a maximum deviation of 0.063 Å. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds, extending in zigzag chains along the b axis. A weak intra-molecular C-H⋯Br hydrogen bond is also observed, which forms an S(6) ring motif. ...[more]

PMID: 22719542

Similar Datasets

2-(5-Bromo-2-methyl-phen-yl)propan-2-ol.

Project description:The title compound, C(10)H(13)BrO, crystallizes with four independent mol-ecules of similar geometry in the asymmetric unit. The crystal packing is stabilized by inter-molecular O-H?O hydrogen bonds, which link the mol-ecules into tetra-mers.

| S-EPMC3009192 | biostudies-literature

4-[(4-Methyl-phen-yl)sulfan-yl]butan-2-one.

Project description:In the title compound, C11H14OS, all non-H atoms are essentially coplanar, with a mean deviation of 0.023?Å. In the crystal, centrosymmetrically related mol-ecules are weakly connected into dimers by pairs of C-H?O inter-actions. The dimers are further linked along the a axis by weak C-H?? and C-H?S inter-actions.

| S-EPMC3884298 | biostudies-literature

1-Methyl-3,3-bis-[(4-methyl-phen-yl)sulfan-yl]piperidin-2-one.

Project description:The piperidone ring in the title compound, C(20)H(23)NOS(2), has a half-chair distorted to a twisted-boat conformation [Q(T) = 0.5200?(17)?Å]. One of the S-bound benzene rings is almost perpendicular to the least-squares plane through the piperidone ring, whereas the other is not [dihedral angles = 75.28?(5) and 46.41?(5)?Å, respectively]. In the crystal, the presence of C-H?O and C-H?? inter-actions leads to the formation of supra-molecular layers in the ab plane.

| S-EPMC3201309 | biostudies-literature

3,3-Bis(4-bromo-phenyl-sulfan-yl)-1-methyl-piperidin-2-one.

Project description:In the title compound, C18H17Br2NOS2, the conformation of the piperidin-2-one ring is based on a half-chair with the methyl-ene C atom diagonally opposite the N atom being 0.649?(3)?Å above the plane of the remaining five atoms (r.m.s. deviation = 0.1205?Å). The S atoms occupy axial and bis-ectional positions, and the dihedral angle between the benzene rings of 59.95?(11)° indicates a splayed disposition. Helical supra-molecular chains along the b axis sustained by C-H?O inter-actions is the major feature of the crystal packing. The chains are connected into a three-dimensional architecture by C-H?Br and C-H?? inter-actions.

| S-EPMC3629608 | biostudies-literature

3,3-Bis[(4-chloro-phen-yl)sulfan-yl]-1-methyl-piperidin-2-one.

Project description:The piperidone ring in the title compound, C(18)H(17)Cl(2)NOS(2), has a distorted half-chair conformation. The S-bound benzene rings are approximately perpendicular to and splayed out of the mean plane through the piperidone ring [dihedral angles = 71.86?(13) and 46.94?(11)°]. In the crystal, C-H?O inter-actions link the mol-ecules into [010] supra-molecular chains with a helical topology. C-H?Cl and C-H?? inter-actions are also present.

| S-EPMC3007065 | biostudies-literature

1-Methyl-4-({5-[(4-methyl-phen-yl)sulfan-yl]pent-yl}sulfan-yl)benzene.

Project description:There are two independent mol-ecules in the asymmetric unit of the title compound, C(19)H(24)S(2). In both mol-ecules, the aliphatic segment of the ligand is in an all-trans conformation: the -S-(CH(2))(5)-S-bridging chain is almost planar (r.m.s. deviation for all non-H atoms = 0.0393 and 0.0796?Å in the two mol-ecules) and maximally extended. Their mean planes form dihedral angles of 4.08?(6)/20.47?(6) and 2.22?(6)/58.19?(6)° with the aromatic rings in the two mol-ecules. The crystal packing is purely governed by weak inter-molecular forces.

| S-EPMC2972162 | biostudies-literature

2,3-Dibromo-3-(4-bromo-phen-yl)-1-[3-(4-meth-oxy-phen-yl)sydnon-4-yl]propan-1-one.

Project description:In the title compound {systematic name: 4-[2,3-dibromo-3-(4-bromo-phen-yl)propano-yl]-3-(4-meth-oxy-phen-yl)-1,2,3-oxa-dia-zol-3-ylium-5-olate}, C(18)H(13)Br(3)N(2)O(4), the central oxadiazole ring, which is essentially planar with a maximum deviation of 0.016 (3) Å, makes dihedral angles of 29.98 (16) and 52.04 (16)°, respectively, with the terminal bromo-substituted and meth-oxy-substituted benzene rings. An intra-molecular C-H⋯O hydrogen bond generates an S(6) ring motif.

| S-EPMC3099938 | biostudies-literature

1,1'-[(2-Bromo-phen-yl)-methyl-ene]-dipyrrolidin-2-one.

Project description:In the title compound, C(15)H(17)BrN(2)O(2), both pyrrolidinone rings adopt envelope conformations. The crystal packing is characterized by short C-Br?O=C inter-actions [Br?O = 3.1730?(13)?Å], leading to supra-molecular dimers. Inter-molecular C-H?O and C-H?? inter-actions are also observed.

| S-EPMC3295531 | biostudies-literature

(E)-3-(4-Fluoro-phen-yl)-1-[4-(methyl-sulfan-yl)phen-yl]prop-2-en-1-one.

Project description:In the title mol-ecule, C(16)H(13)FOS, the dihedral angle between the two benzene rings is 8.68?(6)°. The H atoms of the central enone group are trans and one H atom is involved in a close intra-molecular C-H?O contact. The crystal structure is stabilized by weak C-H?? inter-actions.

| S-EPMC2959522 | biostudies-literature

2,3-Dibromo-3-(2-bromo-phen-yl)-1-(3-phenyl-sydnon-4-yl)propan-1-one.

Project description:IN THE TITLE COMPOUND [SYSTEMATIC NAME: 2,3-dibromo-3-(2-bromo-phen-yl)-1-(5-oxido-3-phenyl-1,2,3-oxadiazol-3-ium-4-yl)propan-1-one], C(17)H(11)Br(3)N(2)O(3), the oxadiazole ring is essentially planar, with a maximum deviation of 0.003?(1)?Å. The -CHBr-CHBr- chain and bromo-phenyl ring are disordered over two sets of sites with a refined occupany ratio of 0.756?(5):0.244?(5). The central oxadiazole ring makes dihedral angles of 54.07?(11) and 13.76?(18)° with the attached phenyl and the major component of the bromo-substituted benzene rings, respectively. The dihedral angle between the major and minor components of the bromo-phenyl rings is 13.4?(5)°. In the crystal structure, mol-ecules are connected by C-H?O hydrogen bonds, forming [010] ribbons.

| S-EPMC3011624 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data